Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer files PARP inhibitor for breast cancer in US, EU

pharmatimesJuly 10, 2018

Tag: TALAZOPARIB , Breast Cancer , FDA

PharmaSources Customer Service